Annual Total Liabilities
$272.29 M
-$78.54 M-22.39%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual total liabilities is $272.29 million, with the most recent change of -$78.54 million (-22.39%) on December 31, 2023.
- During the last 3 years, AKBA annual total liabilities has fallen by -$124.23 million (-31.33%).
- AKBA annual total liabilities is now -40.20% below its all-time high of $455.34 million, reached on December 31, 2021.
Performance
AKBA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$257.54 M
+$3.59 M+1.42%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly total liabilities is $257.54 million, with the most recent change of +$3.59 million (+1.42%) on September 30, 2024.
- Over the past year, AKBA quarterly total liabilities has increased by +$3.59 million (+1.42%).
- AKBA quarterly total liabilities is now -49.43% below its all-time high of $509.24 million, reached on March 31, 2022.
Performance
AKBA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AKBA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | +1.4% |
| 3 y3 years | -31.3% | -43.4% |
| 5 y5 years | -24.5% | -43.4% |
AKBA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.2% | at low | -49.4% | +1.9% |
| 5 y | 5-year | -40.2% | at low | -49.4% | +1.9% |
| alltime | all time | -40.2% | +6863.9% | -49.4% | +6486.8% |
Akebia Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $257.54 M(+1.4%) |
| Jun 2024 | - | $253.95 M(+0.5%) |
| Mar 2024 | - | $252.74 M(-7.2%) |
| Dec 2023 | $272.29 M(-22.4%) | $272.29 M(-0.8%) |
| Sep 2023 | - | $274.42 M(-2.2%) |
| Jun 2023 | - | $280.52 M(-3.7%) |
| Mar 2023 | - | $291.21 M(-17.0%) |
| Dec 2022 | $350.82 M(-23.0%) | $350.82 M(-16.9%) |
| Sep 2022 | - | $422.04 M(-8.2%) |
| Jun 2022 | - | $459.50 M(-9.8%) |
| Mar 2022 | - | $509.24 M(+11.8%) |
| Dec 2021 | $455.34 M(+14.8%) | $455.34 M(-2.1%) |
| Sep 2021 | - | $465.12 M(+6.4%) |
| Jun 2021 | - | $437.23 M(+5.4%) |
| Mar 2021 | - | $414.81 M(+4.6%) |
| Dec 2020 | $396.52 M(+5.3%) | $396.52 M(+10.7%) |
| Sep 2020 | - | $358.18 M(-4.5%) |
| Jun 2020 | - | $374.91 M(-4.2%) |
| Mar 2020 | - | $391.36 M(+4.0%) |
| Dec 2019 | $376.44 M | $376.44 M(+14.9%) |
| Sep 2019 | - | $327.66 M(+7.7%) |
| Jun 2019 | - | $304.17 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $324.41 M(-10.0%) |
| Dec 2018 | $360.61 M(+49.2%) | $360.61 M(+38.0%) |
| Sep 2018 | - | $261.29 M(+5.4%) |
| Jun 2018 | - | $247.86 M(+0.9%) |
| Mar 2018 | - | $245.62 M(+1.6%) |
| Dec 2017 | $241.67 M(+4.1%) | $241.67 M(+1.2%) |
| Sep 2017 | - | $238.71 M(-14.7%) |
| Jun 2017 | - | $279.82 M(+22.4%) |
| Mar 2017 | - | $228.64 M(-1.5%) |
| Dec 2016 | $232.10 M(+1843.5%) | $232.10 M(+239.3%) |
| Sep 2016 | - | $68.41 M(+9.7%) |
| Jun 2016 | - | $62.35 M(+16.2%) |
| Mar 2016 | - | $53.68 M(+349.5%) |
| Dec 2015 | $11.94 M(+72.6%) | $11.94 M(-15.8%) |
| Sep 2015 | - | $14.18 M(+139.7%) |
| Jun 2015 | - | $5.91 M(-33.2%) |
| Mar 2015 | - | $8.85 M(+27.9%) |
| Dec 2014 | $6.92 M(+76.9%) | $6.92 M(+5.5%) |
| Sep 2014 | - | $6.56 M(+36.4%) |
| Jun 2014 | - | $4.81 M(-22.0%) |
| Mar 2014 | - | $6.16 M(+57.6%) |
| Dec 2013 | $3.91 M(-20.6%) | $3.91 M |
| Dec 2012 | $4.92 M | - |
FAQ
- What is Akebia Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics annual total liabilities year-on-year change?
- What is Akebia Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly total liabilities year-on-year change?
What is Akebia Therapeutics annual total liabilities?
The current annual total liabilities of AKBA is $272.29 M
What is the all time high annual total liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total liabilities is $455.34 M
What is Akebia Therapeutics annual total liabilities year-on-year change?
Over the past year, AKBA annual total liabilities has changed by -$78.54 M (-22.39%)
What is Akebia Therapeutics quarterly total liabilities?
The current quarterly total liabilities of AKBA is $257.54 M
What is the all time high quarterly total liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total liabilities is $509.24 M
What is Akebia Therapeutics quarterly total liabilities year-on-year change?
Over the past year, AKBA quarterly total liabilities has changed by +$3.59 M (+1.42%)